Overview

• The initiative, led by Novo Nordisk and Fondazione Banco Farmaceutico with government backing, supplies permanent free insulin and delivery devices to socio-assistance facilities serving indigent diabetics.
• Eight socio-assistance centres in Milan, Rome, Torino, Verona and Palermo are now operational under the first phase of the project.
• Launch ties into Law n.130/2023, which established free nationwide screening for type 1 diabetes and celiac disease in the pediatric population.
• Health ministry data highlight nearly 4 million Italians with diabetes and over 460 000 residents facing healthcare poverty in 2024.
• As part of Novo Nordisk’s global ‘Defeat Diabetes’ initiative, ‘Vulnerabili’ aims to reduce healthcare inequality for the country’s most vulnerable diabetic patients.